Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PI3K/Akt Pathway Inhibitors vs Pembrolizumab in Glioblastoma/Gliosarcoma
NCT02430363Phase 2Unknown
- Sponsor
- Medical Research Council
- Start
- Mar 2013
- Primary completion
- Jan 2016
- Modality
- Small Molecules
- Countries
- 10
01
Overview
A Phase 2 trial of pictilisib, dactolisib, ipatasertib in glioblastoma (GBM), Gliosarcoma (GS), sponsored by Medical Research Council. Status: unknown.
02
Drugs
pictilisibdactolisibipatasertib
03
Conditions
glioblastoma (GBM)Gliosarcoma (GS)
Beyond the preview
Go deeper on NCT02430363.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02430363.